Skip to main content

Table 2 Association between patient/tumor data and pCR in univariate

From: Significance of the neutrophil-to-lymphocyte ratio in predicting the response to neoadjuvant chemotherapy in extremity osteosarcoma: a multicentre retrospective study

Variable n pCR(%) P value
Age (year)    0.669
≤17 56 22(39.3)  
>17 40 14(35.0)  
Sex    0.111
 Male 54 24(44.4)  
 Female 42 12(28.6)  
Tumor location    0.896
 Tibia 40 16(40.0)  
 Femur 44 16(36.4)  
 Others 12 4(33.3)  
Tumor size (cm3)    0.034
  ≤ 195.37 38 20(52.6)  
  > 195.37 58 18(31.0)  
Enneking stage    0.023
 I 28 15(53.6)  
 II 46 16(34.8)  
 III 22 5(22.7)  
Subtype    0.263
 Osteoblastic 58 23(39.7)  
 Chondroblastic 22 6(27.3)  
 Others 16 7(43.8)  
Regimens of NACT    0.261
 AP 36 12(33.3)  
 MAP 60 24(40.0)  
ALP    0.342
 Elevated 50 21(42.0)  
 Normal 46 15(32.6)  
ESR    0.406
 Elevated 70 28(40.0)  
 Normal 26 8(30.8)  
CRP    0.592
 Elevated 64 25(39.1)  
 Normal 32 11(34.4)  
NLR    0.021
 LNLR 50 22(44.0)  
 HNLR 46 14(30.4)  
PLR    0.031
 LPLR 30 16(53.3)  
 HPLR 66 20(30.3)